Associations Between PFA-Measured Aspirin Resistance, Platelet Count, Renal Function, and Angiotensin Receptor...

Area of Science:

• Cardiology
• Pharmacology
• Internal Medicine

Background:

• Aspirin resistance, defined by failed thromboxane inhibition, is a clinical concern.
• Drug-drug interactions are a potential cause of aspirin resistance.
• Understanding factors influencing aspirin response is crucial for patient management.

Purpose of the Study:

• To investigate the association between aspirin resistance and common cardiovascular medications.
• To determine if angiotensin receptor blockers (ARBs) impact aspirin resistance.
• To explore the role of platelet count and other laboratory markers in this interaction.

Main Methods:

• Aspirin resistance was assessed using the Platelet Function Analyzer-100 system.
• Data from 831 aspirin-treated outpatients were analyzed.
• Multivariate logistic regression was employed to identify significant associations.

Main Results:

• Aspirin resistance was observed in 17.7% of patients.
• Concomitant angiotensin receptor blocker (ARB) treatment and low platelet count were associated with aspirin response.
• In ARB-treated patients, increased creatinine and decreased hematocrit correlated with higher aspirin resistance risk, while platelet count's effect was diminished.

Conclusions:

• Concomitant ARB treatment may decrease aspirin resistance risk in aspirin-treated patients, especially those with low platelet counts.
• The protective effect of ARBs against aspirin resistance appears dependent on platelet count.
• In ARB-treated patients, specific laboratory values like creatinine and hematocrit influence aspirin resistance risk.